Drugs / DA-5217
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07027982 | Jul → Aug 2025 | — | Dong-A ST Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DA-5217 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07027982 ↗ |
| Route | Intravenous | “Intravenous DA-5217” NCT07027982 ↗ |